Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Shares Outstanding (Weighted Average) (2021 - 2025)

Prime Medicine filings provide 5 years of Shares Outstanding (Weighted Average) readings, the most recent being $148.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 25.43% to $148.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $148.8 million, a 25.43% increase, with the full-year FY2025 number at $148.8 million, up 25.43% from a year prior.
  • Shares Outstanding (Weighted Average) hit $148.8 million in Q4 2025 for Prime Medicine, down from $160.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $160.5 million in Q3 2025 to a low of $11.8 million in Q3 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $90.7 million (2023), compared with a mean of $83.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 367.52% in 2023 and later increased 15.52% in 2025.
  • Prime Medicine's Shares Outstanding (Weighted Average) stood at $13.0 million in 2021, then soared by 161.23% to $33.9 million in 2022, then surged by 168.42% to $91.0 million in 2023, then skyrocketed by 30.37% to $118.6 million in 2024, then rose by 25.43% to $148.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $148.8 million (Q4 2025), $160.5 million (Q3 2025), and $129.2 million (Q2 2025) per Business Quant data.